The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


The Journal of Immunology, 2007, 179, 6421 -6428
Copyright © 2007 by The American Association of Immunologists, Inc.

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wang, S.
Right arrow Articles by Yoshida, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wang, S.
Right arrow Articles by Yoshida, H.
Right arrowPubmed/NCBI databases
*Gene*GEO Profiles
*HomoloGene*UniGene
*Substance via MeSH

Augmentation of Antigen-Presenting and Th1-Promoting Functions of Dendritic Cells by WSX-1(IL-27R) Deficiency1

Sen Wang, Yoshiyuki Miyazaki, Yukari Shinozaki and Hiroki Yoshida2

Department of Biomolecular Sciences, Faculty of Medicine, Saga University, Saga, Japan

WSX-1 is the {alpha} subunit of the IL-27R complex expressed by T, B, NK/NKT cells, as well as macrophages and dendritic cells (DCs). Although it has been shown that IL-27 has both stimulatory and inhibitory effects on T cells, little is known on the role of IL-27/WSX-1 on DCs. LPS stimulation of splenic DCs in vivo resulted in prolonged CD80/CD86 expression on WSX-1-deficient DCs over wild-type DCs. Upon LPS stimulation in vitro, WSX-1-deficient DCs expressed Th1-promoting molecules higher than wild-type DCs. In an allogeneic MLR assay, WSX-1-deficient DCs were more potent than wild-type DCs in the induction of proliferation of and IFN-{gamma} production by responder cell proliferation. When cocultured with purified NK cells, WSX-1-deficient DCs induced higher IFN-{gamma} production and killing activity of NK cells than wild-type DCs. As such, Ag-pulsed WSX-1-deficient DCs induced Th1-biased strong immune responses over wild-type DCs when transferred in vivo. WSX-1-deficient DCs were hyperreactive to LPS stimulation as compared with wild-type DCs by cytokine production. IL-27 suppressed LPS-induced CD80/86 expression and cytokine production by DCs in vitro. Thus, our study demonstrated that IL-27/WSX-1 signaling potently down-regulates APC function and Th1-promoting function of DCs to modulate overall immune responses.

The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked advertisement in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

1 This study was supported in part by grants from the Ministry of Education, Science, Sports and Culture (to H.Y.), Japan Society for the Promotion of Science (to H.Y.), Japan Research Foundation for Clinical Pharmacology (to H.Y.), Sumitomo Foundation, Basic Science Research Projects (to H.Y.), Naito Foundation (to H.Y.), and Takeda Science Foundation. This work was also supported by the president’s research project expenditure of Saga University (to H.Y.). W.S. is a recipient of the Japan Society for the Promotion of Science Postdoctoral Fellowship for foreign researchers.

2 Address correspondence and reprint requests to Dr. Hiroki Yoshida, Department of Biomolecular Sciences, Faculty of Medicine, Saga University, Nabeshima, Saga, Japan. E-mail address: yoshidah{at}med.saga-u.ac.jp

3 Abbreviations used in this paper: DC, dendritic cell; BM, bone marrow; WT, wild type; KLH, keyhole limpet hemocyanin; LN, lymph node; MFI, mean fluorescence intensity; SOCS, suppressor of cytokine signaling; BM, bone marrow; KO, knockout.




This article has been cited by other articles:


Home page
J. Immunol.Home page
M. El-behi, B. Ciric, S. Yu, G.-X. Zhang, D. C. Fitzgerald, and A. Rostami
Differential Effect of IL-27 on Developing versus Committed Th17 Cells
J. Immunol., October 15, 2009; 183(8): 4957 - 4967.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
G. Murugaiyan, A. Mittal, R. Lopez-Diego, L. M. Maier, D. E. Anderson, and H. L. Weiner
IL-27 Is a Key Regulator of IL-10 and IL-17 Production by Human CD4+ T Cells
J. Immunol., August 15, 2009; 183(4): 2435 - 2443.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
M. Matsui, T. Kishida, H. Nakano, K. Yoshimoto, M. Shin-Ya, T. Shimada, S. Nakai, J. Imanishi, T. Yoshimoto, Y. Hisa, et al.
Interleukin-27 Activates Natural Killer Cells and Suppresses NK-Resistant Head and Neck Squamous Cell Carcinoma through Inducing Antibody-Dependent Cellular Cytotoxicity
Cancer Res., March 15, 2009; 69(6): 2523 - 2530.
[Abstract] [Full Text] [PDF]


Home page
Int ImmunolHome page
H. Shiraishi, H. Yoshida, K. Saeki, Y. Miura, S. Watanabe, T. Ishizaki, M. Hashimoto, G. Takaesu, T. Kobayashi, and A. Yoshimura
Prostaglandin E2 is a major soluble factor produced by stromal cells for preventing inflammatory cytokine production from dendritic cells
Int. Immunol., September 1, 2008; 20(9): 1219 - 1229.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
G. D. Kalliolias and L. B. Ivashkiv
IL-27 Activates Human Monocytes via STAT1 and Suppresses IL-10 Production but the Inflammatory Functions of IL-27 Are Abrogated by TLRs and p38
J. Immunol., May 1, 2008; 180(9): 6325 - 6333.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2007 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2007 by The American Association of Immunologists, Inc. All rights reserved.